Here are four ways Dr. Gottlieb seeks to address high drug costs. 1. Increase generic competition. Dr. Gottlieb told Bloomberg the FDA is exploring how to prioritize the review of applications for ...

Replacing the combination of brand-name, antiretroviral drugs currently recommended for control of HIV infection with soon-to-be-available generic medications could save the U.S. health care ...

Generic medicines, which are clinically equivalent to their branded counterparts, are a cornerstone in efforts to improve healthcare affordability and broaden patient access to essential treatments.

Still, the generic competition could cause Vascepa sales to erode between 6% to 22% by 2023, Leerink estimated. The analysts said that erosion could be lessened if Amarin’s new strategy works ...